Recruitment

Recruitment Status
Completed
Estimated Enrollment
30

Inclusion Criterias

athletes with and without exercise-induced bronchoconstriction
trained, experienced cyclists
maximal oxygen consumption of at least 50ml/kg/min or 4l/min for women; and 60ml/kg/min or 5l/min for men
athletes with and without exercise-induced bronchoconstriction
trained, experienced cyclists
maximal oxygen consumption of at least 50ml/kg/min or 4l/min for women; and 60ml/kg/min or 5l/min for men

Exclusion Criterias

smoking
maximal oxygen consumption of less than 50ml/kg/min or 4L/min for women; and less than 60ml/kg/min or 5L/min for men
any uncontrolled heart or lung condition
...
smoking
maximal oxygen consumption of less than 50ml/kg/min or 4L/min for women; and less than 60ml/kg/min or 5L/min for men
any uncontrolled heart or lung condition
pregnancy

Summary

Conditions
  • Bronchoconstriction
  • Cycling Performance
  • Inhaled Salbutamol
Type
Interventional
Phase
Phase 4
Design
  • Allocation: Randomized
  • Intervention Model: Crossover Assignment
  • Masking: Double (Participant, Investigator)
  • Primary Purpose: Basic Science

Participation Requirements

Age
Between 19 years and 45 years
Gender
Both males and females

Inclusion Criterias

athletes with and without exercise-induced bronchoconstriction
trained, experienced cyclists
maximal oxygen consumption of at least 50ml/kg/min or 4l/min for women; and 60ml/kg/min or 5l/min for men
athletes with and without exercise-induced bronchoconstriction
trained, experienced cyclists
maximal oxygen consumption of at least 50ml/kg/min or 4l/min for women; and 60ml/kg/min or 5l/min for men

Exclusion Criterias

smoking
maximal oxygen consumption of less than 50ml/kg/min or 4L/min for women; and less than 60ml/kg/min or 5L/min for men
any uncontrolled heart or lung condition
...
smoking
maximal oxygen consumption of less than 50ml/kg/min or 4L/min for women; and less than 60ml/kg/min or 5L/min for men
any uncontrolled heart or lung condition
pregnancy

Locations

Vancouver, British Columbia, V6T 1Z1
Vancouver, British Columbia, V6T 1Z1

Tracking Information

NCT #
NCT01903785
Collaborators
World Anti-doping Agency
Investigators
  • Principal Investigator: Michael S Koehle, MD, PhD University of British Columbia
  • Michael S Koehle, MD, PhD University of British Columbia